Which has grown faster, LMAT or SRPT?

Over the past five years, SRPT grew revenue faster — LMAT at a 11.76% CAGR versus SRPT at 26.90%.

Does LMAT or SRPT pay a bigger dividend?

LMAT pays a dividend (1.17% yield), while SRPT has no payments in the available dividend history.

Is LMAT or SRPT more profitable?

LMAT runs the higher net margin — LMAT at 25.02% versus SRPT at -6.93%.

How have LMAT and SRPT total returns compared?

Over the past 10 years, LMAT delivered 16.21% and SRPT delivered -11.94% annualized total return. Past performance doesn't predict future results.

LeMaitre Vascular, Inc. (LMAT) vs Sarepta Therapeutics, Inc. (SRPT)

A side-by-side comparison of LeMaitre Vascular, Inc. and Sarepta Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LMAT

LeMaitre Vascular, Inc.

$1.81B

$79.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SRPT

Sarepta Therapeutics, Inc.

$1.82B

$17.23HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT

Total return — LMAT vs SRPT

growth of $100 · dividends reinvested · last 10y

LMAT +349.0% (+16.2%/yr)SRPT -71.5% (-11.8%/yr)LMAT compounded faster over this window

Log scale — wide-divergence pair

LMAT SRPT

LMAT vs SRPT: by the numbers

•SRPT is the larger company ($1.82B vs $1.81B market cap).
•LMAT is profitable (25.02% net margin) while SRPT runs a net loss (-6.93%).
•SRPT grew revenue faster over the past five years (26.90% vs 11.76% CAGR).
•LMAT pays a dividend (1.17% yield), while SRPT has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	LMAT	SRPT
P/E ratio	27.74	N/A
Forward P/E	27.52	5.36
PEG ratio	1.43	N/A
P/S ratio	6.88	0.92
P/B ratio	4.30	1.19
EV / EBITDA	21.67	N/A
FCF yield	4.09%	N/A

Profitability

Metric	LMAT	SRPT
Gross margin	72.90%	58.56%
Operating margin	29.46%	-29.92%
Net margin	25.02%	-6.93%
ROE	15.62%	-8.95%
ROIC	9.81%	-5.33%

Dividends

Metric	LMAT	SRPT
Dividend yield	1.17%	N/A
Payout ratio	33.33%	N/A

Growth (annualized)

Metric	LMAT	SRPT
Revenue CAGR (5Y)	11.76%	26.90%
EPS CAGR (5Y)	19.42%	N/A
FCF CAGR (5Y)	13.06%	N/A
Total return CAGR (5Y)	9.79%	-28.74%

Frequently asked

Which has grown faster, LMAT or SRPT?: Over the past five years, SRPT grew revenue faster — LMAT at a 11.76% CAGR versus SRPT at 26.90%.
Does LMAT or SRPT pay a bigger dividend?: LMAT pays a dividend (1.17% yield), while SRPT has no payments in the available dividend history.
Is LMAT or SRPT more profitable?: LMAT runs the higher net margin — LMAT at 25.02% versus SRPT at -6.93%.
How have LMAT and SRPT total returns compared?: Over the past 10 years, LMAT delivered 16.21% and SRPT delivered -11.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LMAT analysis Full SRPT analysis Interactive comparison tool

Dig into the metrics

LeMaitre Vascular P/E ratio LeMaitre Vascular dividend yield LeMaitre Vascular ROE Sarepta Therapeutics ROE LeMaitre Vascular operating margin Sarepta Therapeutics operating margin LeMaitre Vascular revenue growth Sarepta Therapeutics revenue growth LeMaitre Vascular free cash flow Sarepta Therapeutics free cash flow

LeMaitre Vascular & Sarepta Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.